4:08 AM
Mar 08, 2018
 |  BC Extra  |  Financial News

Prevail raises $75 million series A

Prevail Therapeutics Inc. (New York, N.Y.) raised $75 million in a series A round from OrbiMed Advisors, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners, Boxer Capital, Adage Capital Management...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >